| 44.25 Delayed Data As of 3:59pm ET |  -0.16 / -0.36%Today’s Change | 20.10 Today|||52-Week Range 300.00 | -37.27% Year-to-Date |
| Should You Buy a Cannabis ETF? 12:24pm / Zacks.com - Paid Partner Content | The 6 Best Marijuana Stocks in June Jul 08 / MotleyFool.com - Paid Partner Content |
| U.S. CBD Sales to Grow an Average of 107% Annually Through 2023 Jul 14 / MotleyFool.com - Paid Partner Content | Thinking about buying stock in Aethlon Medical, Alibaba, Canopy Growth, Eros Internat... Jul 02 / PR NewswirePRN - Paid Partner Content |
| 3 Pot Stocks Short-Sellers Are Targeting Jul 11 / MotleyFool.com - Paid Partner Content | Blueberries Announces Appointment of Chief Financial Officer Jun 24 / GlobeNewswirePNW - Paid Partner Content |
| Previous close | 44.41 |
| Today’s open | 44.37 |
| Day’s range | 44.06 - 45.48 |
| Volume | 972,867 |
| Average volume (3 months) | 1,638,057 |
| Market cap | $4.2B |
| Earnings growth (last year) | -873.51% |
| Earnings growth (this year) | -26.73% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +110.00% |
| P/E ratio | NM |
| Price/Sales | 135.76 |
| Price/Book | 20.43 |
| Today’s change | Today’s % change | |
|---|---|---|
| BPMCBlueprint Medicines ... | +1.59 | +1.68% |
| MRNAModerna Inc | -0.11 | -0.78% |
| ONCESpark Therapeutics I... | -0.65 | -0.67% |
| ALLOAllogene Therapeutic... | +0.51 | +1.84% |
| Next reporting date | August 28, 2019 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $43.1M |
| Annual profit (last year) | -$67.7M |
| Net profit margin | -157.02% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Brendan Kennedy |
Executive Vice President- Operations Greg Christopher |
Corporate headquarters Nanaimo, British Columbia |
